RELMADA THERAPEUTICS, INC. — All Filings
581 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-KT
10-Q
144
3
3/A
4
4/A
424B3
424B5
5
5/A
8-A12B
8-A12G
8-K
8-K/A
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DFAN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-032403 | Mar 20, 2026 | Mar 19, 2026 |
| 10-K | ANNUAL REPORT | 0001213900-26-031862 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-26-024918 | Mar 9, 2026 | — |
| SCHEDULE 13G/A | — | 0002050709-26-000007 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001027 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-000914 | Feb 12, 2026 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-010313 | Jan 30, 2026 | — |
| 4 | — | 0001213900-25-121974 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | — | 0001213900-25-121973 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | — | 0001213900-25-121972 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | — | 0001213900-25-121971 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | — | 0001213900-25-121969 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | — | 0001213900-25-121968 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | — | 0001213900-25-121967 | Dec 16, 2025 | Dec 12, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-121461 | Dec 15, 2025 | Dec 12, 2025 |
| SCHEDULE 13G | — | 0001193125-25-283441 | Nov 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-110088 | Nov 13, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-109983 | Nov 13, 2025 | Sep 30, 2025 |
| 4 | — | 0001213900-25-106836 | Nov 6, 2025 | Nov 5, 2025 |
| 4 | — | 0001213900-25-106838 | Nov 6, 2025 | Nov 5, 2025 |
| 4 | — | 0001213900-25-106837 | Nov 6, 2025 | Nov 5, 2025 |
| 4 | — | 0001213900-25-106835 | Nov 6, 2025 | Nov 5, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-106398 | Nov 5, 2025 | Nov 4, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-106396 | Nov 5, 2025 | — |
| FWP | FREE WRITING PROSPECTUS | 0001213900-25-105641 | Nov 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-105593 | Nov 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-088360 | Sep 17, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-087926 | Sep 16, 2025 | Sep 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-086389 | Sep 10, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-082910 | Sep 2, 2025 | Aug 29, 2025 |
| 4 | — | 0001213900-25-081837 | Aug 28, 2025 | Aug 26, 2025 |
| SCHEDULE 13G/A | — | 0002050709-25-000005 | Aug 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-073130 | Aug 7, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-073073 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-066995 | Jul 23, 2025 | Jul 22, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-062803 | Jul 10, 2025 | Jul 7, 2025 |
| 4 | — | 0001213900-25-059870 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | — | 0001213900-25-059869 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | — | 0001213900-25-059868 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | — | 0001213900-25-059867 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | — | 0001213900-25-059866 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | — | 0001213900-25-059865 | Jun 30, 2025 | Jun 26, 2025 |
| 4 | — | 0001213900-25-059864 | Jun 30, 2025 | Jun 26, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-055334 | Jun 18, 2025 | Jun 17, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-053957 | Jun 13, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-047805 | May 27, 2025 | May 23, 2025 |
| 4 | — | 0001213900-25-046088 | May 20, 2025 | May 16, 2025 |
| 4 | — | 0001213900-25-046087 | May 20, 2025 | May 16, 2025 |
| 4 | — | 0001213900-25-046086 | May 20, 2025 | May 16, 2025 |
| 4 | — | 0001213900-25-046085 | May 20, 2025 | May 16, 2025 |